Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Impella
MedTech
J&J’s Impella pumps miss the mark in 2 major PCI studies
Two separate randomized trials failed to illustrate Impella's benefits in specific cases of patients with blocked coronary arteries.
Conor Hale
Mar 30, 2026 3:20pm
J&J delivers 10-year Impella gains in severe heart attacks
Sep 2, 2025 1:30pm
FDA opens use of J&J's Impella heart pumps to pediatric patients
Dec 12, 2024 2:30pm
J&J's Abiomed pump reduces deaths after widowmaker heart attacks
Apr 8, 2024 12:12pm
J&J's Abiomed lands FDA warning letter over Impella heart pumps
Oct 13, 2023 10:42am
J&J's Abiomed updates labeling for certain Impella heart pumps
Aug 18, 2023 10:18am
